USPTO serial 98344153
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $600
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Felicia J. Boyd
Felicia J. Boyd Norton Rose Fulbright US LLP60 South Sixth Street, Suite 3100Minneapolis, MN 55402United States| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Pharmaceutical cost management services; medical cost management; medical cost management in the field of pharmaceuticals; business data analysis and reporting services in the fields of healthcare, pharmaceuticals, and consumer behavior, all for business purposes; providing information in the fields of business management of prescription drug savings, and business management of reduction of out-of-pocket costs and expenses for prescriptions; business management consulting relating to prescription drug costs using analytic and predictive models applied to medical and pharmacy data; consulting services in the field of cost management of drug therapies through medical cost management; consulting services in the field of cost management of drug therapies through medical cost management for site of care and administration of drugs; business administration services, namely, negotiation of business contracts for others with drug manufacturers to enable participant members of pharmacy benefit management clients to obtain discounts on pharmaceuticals; business administration services, namely, negotiation of business contracts for others to enable member populations of pharmacy benefit management clients to obtain discounts and rebates with drug manufacturers; business services provided to the healthcare industry, namely, the collection and reporting of data pertaining to pharmaceuticals for business purposes; specialty retail pharmacy services; providing healthcare operations management services for health plan sponsors, namely, facilitating the administrative coordination of patient care among health plan sponsors, health providers, health facilities, and specialty pharmacies; drug utilization review services; drug formulary business management services; health care utilization and review services; providing business intelligence services in the field of pharmacy benefit management | ACTIVE | — |
| 036 | Pharmacy benefit management services; administration of preferred provider plans for a network of pharmacy providers in the field of specialty pharmaceuticals | ACTIVE | — |
| 044 | Pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consulting services; health care services, namely, disease management programs; medication therapy management, namely, medication review being medication counseling and medical and pharmaceutical consulting services | ACTIVE | — |
| 045 | Providing health care coordination services being case management services, namely, coordinating medical services for patients to access specialty drug therapies | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 25, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 24, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 24, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 25, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 24, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 24, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 24, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 25, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 25, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 24, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 24, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 24, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 12, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 12, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 23, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 3, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 3, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 12, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 12, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 12, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 3, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 5, 2024 | NWAP | NEW APPLICATION ENTERED | — |